article
Closed Access
EN
2004-04-09
Antiviral drugs in current clinical use
Journal of Clinical Virology, Vol. 30, Issue 2, pp. 115–133 (2004)
DOI:
10.1016/j.jcv.2004.02.009
PMID: 15125867
Abstract
No abstract available for this work in the OpenAlex record.
Visit the publisher page for the full text.
Topics
Hepatitis B Virus Studies 1.00
Hepatitis C virus research 1.00
Cytomegalovirus and herpesvirus research 1.00
Field: Medicine · Subfield: Epidemiology
Keywords
Famciclovir,Virology,Lamivudine,Penciclovir,Cidofovir,Medicine,Didanosine,Ribavirin,Ritonavir,Herpes simplex virus
MeSH Terms
Antiviral AgentsAntiviral AgentsAntiviral AgentsAntiviral AgentsAntiviral AgentsAntiviral AgentsCytomegalovirus InfectionsCytomegalovirus Infections
UN Sustainable Development Goals
- Good health and well-being (0.84)
All Available Versions
- Landing page — Journal of Clinical Virology publishedVersion
- Landing page — PubMed publishedVersion
Citations by Year
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| 13 | 18 | 21 | 25 | 34 | 37 | 45 | 25 | 35 | 27 |
41.18
FWCI
100%
Normalized Pctile
18
References
1
Authors
More from Journal of Clinical Virology
- Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 2020 · 1196
- The epidemiology of human papillomavirus infections 2005 · 975
- Antiviral drugs in current clinical use 2004 · 951
- Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past 2020 · 932
- The papillomavirus life cycle 2005 · 858
Continue on JournalsHub
Put what you just read into practice with these free tools.